Search the Appendices of Resolution CM/Res(2018)1
2208 found
INN | ATC Code ▼ | Country | Classification | Last update | MA Number | Registration date | Status | |
---|---|---|---|---|---|---|---|---|
OZANIMOD | L04AE02 | PT | POM | 05-10-2020 | EMEA/H/C/004835 | 20-05-2020 | VALID | |
FINGOLIMOD | L04AE01 | PT | POM | VALID | ||||
VOCLOSPORIN | L04AD03 | PT | POM | 22-10-2024 | EMEA/H/C/005256 | 15-09-2022 | VALID | |
TACROLIMUS | L04AD02 | PT | POM | VALID | ||||
CICLOSPORIN | L04AD01 | PT | POM | VALID | ||||
MIRIKIZUMAB | L04AC24 | PT | POM | 22-10-2024 | EMEA/H/C/005122 | 26-05-2023 | VALID | |
SPESOLIMAB | L04AC22 | PT | POM | 22-10-2024 | EMEA/H/C/005874 | 09-12-2022 | VALID | |
BIMEKIZUMAB | L04AC21 | PT | POM | 13-10-2021 | EMEA/H/C/005316 | 20-08-2021 | VALID | |
SATRALIZUMAB | L04AC19 | PT | POM | 13-10-2021 | EMEA/H/C/004788 | 24-06-2021 | VALID | |
RISANKIZUMAB | L04AC18 | PT | POM | VALID | ||||
TILDRAKIZUMAB | L04AC17 | PT | POM | 14-11-2018 | EMEA/H/C/004514 | 17-09-2018 | VALID | |
GUSELKUMAB | L04AC16 | PT | POM | 14-11-2018 | EMEA/H/C/004271 | 15-11-2017 | VALID | |
SARILUMAB | L04AC14 | PT | POM | 06-11-2017 | EMEA/H/C/004254 | 23-06-2017 | VALID | |
IXEKIZUMAB | L04AC13 | PT | POM | 22-08-2017 | EMEA/H/C/003943 | 25-04-2016 | VALID | |
BRODALUMAB | L04AC12 | PT | POM | 06-11-2017 | EMEA/H/C/003959 | 17-07-2017 | VALID | |
SECUKINUMAB | L04AC10 | PT | POM | VALID | ||||
USTEKINUMAB | L04AC05 | PT | I | None | VALID | |||
ANAKINRA | L04AC03 | PT | POM | VALID | ||||
BASILIXIMAB | L04AC02 | PT | POM | VALID | ||||
DACLIZUMAB | L04AC01 | PT | Not authorised | 13-11-2018 | VALID | |||
GOLIMUMAB | L04AB06 | PT | POM | VALID | ||||
CERTOLIZUMAB PEGOL | L04AB05 | PT | POM | VALID | ||||
ADALIMUMAB | L04AB04 | PT | POM | VALID | ||||
INFLIXIMAB | L04AB02 | PT | POM | VALID | ||||
ETANERCEPT | L04AB01 | PT | POM | VALID | ||||
EFGARTIGIMOD ALFA | L04AA58 | PT | POM | 28-10-2024 | EMEA/H/C/005849 | 10-08-2022 | VALID | |
IMLIFIDASE | L04AA41 | PT | Not authorised | 07-10-2020 | VALID | |||
CLADRIBINE | L04AA40 | PT | POM | VALID | ||||
ABATACEPT | L04AA24 | PT | POM | VALID | ||||
MYCOPHENOLIC ACID | L04AA06 | PT | POM | 27-02-2017 | PT/H/1225/002/ | 19-02-2015 | VALID | |
BCG VACCINE | L03AX03 | PT | POM | VALID | ||||
LENTINAN | L03AX01 | PT | Not authorised | VALID | ||||
ALDESLEUKIN | L03AC01 | PT | POM | 05-02-2019 | VALID | |||
ROPEGINTERFERON ALFA-2B | L03AB15 | PT | POM | VALID | ||||
LIPEGFILGRASTIM | L03AA14 | PT | POM | VALID | ||||
PEGFILGRASTIM | L03AA13 | PT | POM | VALID | ||||
FILGRASTIM | L03AA02 | PT | POM | VALID | ||||
RELUGOLIX | L02BX04 | PT | POM | 22-10-2024 | EMEA/H/C/005353 | 29-04-2022 | VALID | |
ABIRATERONE | L02BX03 | PT | POM | VALID | ||||
ABARELIX | L02BX01 | PT | Not authorised | VALID | ||||
DAROLUTAMIDE | L02BB06 | PT | POM | 05-10-2020 | EMEA/H/C/004790 | 27-03-2020 | VALID | |
APALUTAMIDE | L02BB05 | PT | POM | 05-06-2020 | EMEA/H/C/004452 | 14-01-2019 | VALID | |
ENZALUTAMIDE | L02BB04 | PT | POM | None | VALID | |||
BICALUTAMIDE | L02BB03 | PT | Currently not available | PT/H/0667/002/ | 18-06-2012 | VALID | ||
FULVESTRANT | L02BA03 | PT | POM | 07-04-2016 | PT/H/1309/001/ | 05-08-2015 | VALID | |
TAMOXIFEN | L02BA01 | PT | POM | VALID | ||||
GOSERELIN | L02AE03 | PT | POM | 22-08-2017 | PT/H/1276/001/ | 08-10-2015 | VALID | |
LEUPRORELIN | L02AE02 | PT | POM | VALID | ||||
MEDROXYPROGESTERONE | L02AB02 | PT | POM | VALID | ||||
CYTARABINE AND DAUNORUBICIN | L01XY01 | PT | POM | 14-11-2018 | EMEA/H/C/004282 | 21-09-2018 | VALID |